ROP16-Mediated Activation of STAT6 Suppresses Host Cell Reactive Oxygen Species Production, Facilitating Type III Toxoplasma gondii Growth and Survival

por Kochanowsky, Joshua A., Thomas, Kaitlin K., Koshy, Anita A.
Publicado 2021

ROP16-mediated activation of STAT6 enhances cyst development of type III Toxoplasma gondii in neurons

por Kochanowsky, Joshua A., Chandrasekaran, Sambamurthy, Sanchez, Jacqueline R., Thomas, Kaitlin K., Koshy, Anita A.
Publicado 2023

The ROP16(III)-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival

por Tuladhar, Shraddha, Kochanowsky, Joshua A., Bhaskara, Apoorva, Ghotmi, Yarah, Chandrasekaran, Sambamurthy, Koshy, Anita A.
Publicado 2019

IFN-γ stimulated murine and human neurons mount anti-parasitic defenses against the intracellular parasite Toxoplasma gondii

por Chandrasekaran, Sambamurthy, Kochanowsky, Joshua A., Merritt, Emily F., Lagas, Joseph S., Swannigan, Ayesha, Koshy, Anita A.
Publicado 2022

The Toxoplasma gondii virulence factor ROP16 acts in cis and trans, and suppresses T cell responses

por Chen, Longfei, Christian, David A., Kochanowsky, Joshua A., Phan, Anthony T., Clark, Joseph T., Wang, Shuai, Berry, Corbett, Oh, Jung, Chen, Xiaoguang, Roos, David S., Beiting, Daniel P., Koshy, Anita A., Hunter, Christopher A.
Publicado 2020